Diabetic Angiopathies

"Diabetic Angiopathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

VASCULAR DISEASES that are associated with DIABETES MELLITUS.

Descriptor ID	D003925
MeSH Number(s)	C14.907.320 C19.246.099.500
Concept/Terms	Diabetic Angiopathies Diabetic Angiopathies Angiopathies, Diabetic Angiopathy, Diabetic Diabetic Angiopathy Diabetic Vascular Diseases Diabetic Vascular Disease Vascular Disease, Diabetic Vascular Diseases, Diabetic Diabetic Vascular Complications Diabetic Vascular Complication Vascular Complication, Diabetic Vascular Complications, Diabetic Microangiopathy, Diabetic Microangiopathy, Diabetic Diabetic Microangiopathies Diabetic Microangiopathy Microangiopathies, Diabetic

Below are MeSH descriptors whose meaning is more general than "Diabetic Angiopathies".

Diseases [C]
Cardiovascular Diseases [C14]
Vascular Diseases [C14.907]
Diabetic Angiopathies [C14.907.320]
Endocrine System Diseases [C19]
Diabetes Mellitus [C19.246]
Diabetes Complications [C19.246.099]
Diabetic Angiopathies [C19.246.099.500]

Below are MeSH descriptors whose meaning is related to "Diabetic Angiopathies".

Below are MeSH descriptors whose meaning is more specific than "Diabetic Angiopathies".

Diabetic Angiopathies
Diabetic Foot
Diabetic Retinopathy

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Diabetic Angiopathies" by people in this website by year, and whether "Diabetic Angiopathies" was a major or minor topic of these publications.

Bar chart showing 24 publications over 17 distinct years, with a maximum of 3 publications in 2003 and 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2003	1	2	3
2004	2	0	2
2005	0	1	1
2006	1	0	1
2007	0	1	1
2008	1	1	2
2009	1	1	2
2010	1	0	1
2013	1	0	1
2015	1	0	1
2017	1	0	1
2018	3	0	3
2019	1	0	1
2020	0	1	1
2022	1	0	1
2023	1	0	1

Below are the most recent publications written about "Diabetic Angiopathies" by people in Profiles.

Shah BR, Austin PC, Ivers NM, Katz A, Singer A, Sirski M, Thiruchelvam D, Tu K. Risk Prediction Scores for Type 2 Diabetes Microvascular and Cardiovascular Complications Derived and Validated With Real-world Data From 2 Provinces: The DIabeteS COmplications (DISCO) Risk Scores. Can J Diabetes. 2024 Apr; 48(3):188-194.e5.

View in: PubMed
Hamamoto Y, Ouhara K, Miyagawa T, Shintani T, Komatsu N, Kajiya M, Matsuda S, Fujita T, Sasaki S, Iwata T, Ohno H, Yoneda M, Mizuno N, Kurihara H. Masticatory dysfunction in patients with diabetic neuropathy: A cross-sectional study. PLoS One. 2022; 17(6):e0269594.

View in: PubMed
Davidson MB. Metformin Should Not Be Used to Treat Prediabetes. Diabetes Care. 2020 09; 43(9):1983-1987.

View in: PubMed
Tromp J, Lim SL, Tay WT, Teng TK, Chandramouli C, Ouwerkerk W, Wander GS, Sawhney JPS, Yap J, MacDonald MR, Ling LH, Sattar N, McMurray JJV, Richards AM, Anand I, Lam CSP. Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction. Diabetes Care. 2019 09; 42(9):1792-1799.

View in: PubMed
Bancks MP, Ning H, Allen NB, Bertoni AG, Carnethon MR, Correa A, Echouffo-Tcheugui JB, Lange LA, Lloyd-Jones DM, Wilkins JT. Long-term Absolute Risk for Cardiovascular Disease Stratified by Fasting Glucose Level. Diabetes Care. 2019 03; 42(3):457-465.

View in: PubMed
Rosenson RS, Chen Q, Najera SD, Lee ML, Cho DJ. Ticagrelor and the Prevention of Microvascular Complications in Diabetes Patients with Lower Extremity Arterial Disease; Rationale and Design of the Hema-Kinesis Trial. Cardiovasc Drugs Ther. 2018 10; 32(5):443-451.

View in: PubMed
Arnold SV, Yap J, Lam CSP, Tang F, Tay WT, Teng THK, McGuire DK, Januzzi JL, Fonarow GC, Masoudi FA, Kosiborod M. Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparison. Diabetes Obes Metab. 2019 02; 21(2):261-266.

View in: PubMed
Sabo S, Denman Champion C, Bell ML, Cornejo Vucovich E, Ingram M, Valenica C, Castro Vasquez MDC, Gonzalez-Fagoaga E, Geurnsey de Zapien J, Rosales CB. Meta Salud Diabetes study protocol: a cluster-randomised trial to reduce cardiovascular risk among a diabetic population of Mexico. BMJ Open. 2018 03 12; 8(3):e020762.

View in: PubMed
Nguyen E, Coleman CI, Nair S, Weeda ER. Cost-utility of empagliflozin in patients with type 2 diabetes at high cardiovascular risk. J Diabetes Complications. 2018 02; 32(2):210-215.

View in: PubMed
Darrow AL, Shohet RV. Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes. Cardiovasc Diabetol. 2015 Jun 06; 14:73.

View in: PubMed

People

Explore

Similar Concepts

Top Journals